MRI Spectrum of Brain Involvement in Sphingosine-1-Phosphate Lyase Insufficiency Syndrome

被引:18
|
作者
Martin, K. W. [1 ]
Weaver, N. [2 ]
Alhasan, K. [3 ]
Gumus, E. [4 ]
Sullivan, B. R. [5 ,6 ]
Zenker, M. [7 ]
Hildebrandt, F. [8 ]
Saba, J. D. [9 ]
机构
[1] UCSF Benioff Childrens Hosp Oakland, Dept Radiol KWM, Oakland, CA USA
[2] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA
[3] King Saud Univ, Coll Med, Dept Pediat, Riyadh, Saudi Arabia
[4] Harran Univ, Dept Med, Sanliurfa, Turkey
[5] Childrens Mercy, Div Clin Genet, Kansas City, MO USA
[6] Univ Missouri, Dept Pediat, Kansas City, MO 64110 USA
[7] Otto von Guericke Univ, Inst Genet, Magdeburg, Germany
[8] Harvard Med Sch, Boston Childrens Hosp, Dept Pediat, Boston, MA 02115 USA
[9] Univ Calif San Francisco, UCSF Dept Pediat, San Francisco, CA 94143 USA
基金
美国国家卫生研究院;
关键词
SPHINGOSINE PHOSPHATE LYASE; ADRENAL INSUFFICIENCY; NEPHROTIC SYNDROME; 1-PHOSPHATE; NEURODEGENERATION; DEFICIENCY; MUTATIONS; SGPL1;
D O I
10.3174/ajnr.A6746
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
SGPL1encodes sphingosine-1-phosphate lyase, the final enzyme of sphingolipid metabolism. In 2017, a condition featuring steroid-resistant nephrotic syndrome and/or adrenal insufficiency associated with pathogenicSGPL1variants was reported. In addition to the main features of the disease, patients often exhibit a range of neurologic deficits. In a handful of cases, brain imaging results were described. However, high-quality imaging results and a systematic analysis of brain MR imaging findings associated with the condition are lacking. In this study, MR images from 4 new patients and additional published case reports were reviewed by a pediatric neuroradiologist. Analysis reveals recurring patterns of features in affected patients, including isolated callosal dysgenesis and prominent involvement of the globus pallidus, thalamus, and dentate nucleus, with progressive atrophy and worsening of brain lesions. MR imaging findings of abnormal deep gray nuclei, microcephaly, or callosal dysgenesis in an infant or young child exhibiting other typical clinical features of sphingosine-1-phosphate lyase insufficiency syndrome should trigger prompt genetic testing forSGPL1mutations.
引用
收藏
页码:1943 / 1948
页数:6
相关论文
共 50 条
  • [21] Clinical presentation and management challenges of sphingosine-1-phosphate lyase insufficiency syndrome associated with an SGPL1 variant: a case report
    Saeedi, Vahid
    Rahimzadeh, Nahid
    Ehsanipour, Fahimeh
    Shalbaf, Neda
    Farahi, Amirhosein
    Rashidi, Khalil
    Kamalzadeh, Leila
    BMC PEDIATRICS, 2025, 25 (01)
  • [22] Fluorimetric determination of sphingosine-1-phosphate lyase activity.
    Bedia, C.
    Casas, J.
    Fabrias, G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 374 (04) : 337 - 337
  • [23] A retrospective analysis of endocrine disease in sphingosine-1-phosphate lyase insufficiency: case series and literature review
    Maharaj, Avinaash
    Kwong, Ruth
    Williams, Jack
    Smith, Christopher
    Storr, Helen
    Krone, Ruth
    Braslavsky, Debora
    Clemente, Maria
    Ram, Nanik
    Banerjee, Indraneel
    Cetinkaya, Semra
    Buonocore, Federica
    Guran, Tulay
    Achermann, John C.
    Metherell, Louise
    Prasad, Rathi
    ENDOCRINE CONNECTIONS, 2022, 11 (08)
  • [24] A Mechanism-Based Sphingosine-1-phosphate Lyase Inhibitor
    Pons, Guillem
    Riba, Daniel
    Casasampere, Mireia
    Izquierdo, Eduardo
    Abad, Jose-Luis
    Fabrias, Gemma
    Rodriguez Ortega, Pilar G.
    Lopez-Gonzalez, Juan J.
    Montejo, Manuel
    Casas, Josefina
    Delgado, Antonio
    JOURNAL OF ORGANIC CHEMISTRY, 2020, 85 (02): : 419 - 429
  • [25] Sphingosine-1-phosphate lyase in immunity and cancer: silencing the siren
    Bandhuvula, Padmavathi
    Saba, Julie D.
    TRENDS IN MOLECULAR MEDICINE, 2007, 13 (05) : 210 - 217
  • [26] Recent Insight into the Role of Sphingosine-1-Phosphate Lyase in Neurodegeneration
    Wieczorek, Iga
    Strosznajder, Robert Piotr
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [27] Cellular assay for the characterization of sphingosine-1-phosphate lyase inhibitors
    Billich, Andreas
    Beerli, Christian
    Bergmann, Reinhard
    Bruns, Christian
    Loetscher, Erika
    ANALYTICAL BIOCHEMISTRY, 2013, 434 (02) : 247 - 253
  • [28] Inhibition of Sphingosine-1-Phosphate Lyase for the Treatment of Autoimmune Disorders
    Bagdanoff, Jeffrey T.
    Donoviel, Michael S.
    Nouraldeen, Amr
    Tarver, James
    Fu, Qinghong
    Carlsen, Marianne
    Jessop, Theodore C.
    Zhang, Haiming
    Hazelwood, Jill
    Nguyen, Huy
    Baugh, Simon D. P.
    Gardyan, Michael
    Terranova, Kristen M.
    Barbosa, Joseph
    Yan, Jack
    Bednarz, Mark
    Layek, Suman
    Courtney, Lawrence F.
    Taylor, Jerry
    Digeorge-Foushee, Ann Marie
    Gopinathan, Suma
    Bruce, Debra
    Smith, Traci
    Moran, Liam
    O'Neill, Emily
    Kramer, Jeff
    Lai, Zhong
    Kimball, S. David
    Liu, Qingyun
    Sun, Weimei
    Yu, Sean
    Swaffield, Jonathan
    Wilson, Alan
    Main, Alan
    Carson, Kenneth G.
    Oravecz, Tamas
    Augeri, David J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (13) : 3941 - 3953
  • [29] Overexpression and biology of the human sphingosine-1-phosphate lyase gene
    Reiss, UM
    Zhou, JH
    Saba, JD
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 333A - 333A
  • [30] Deficiency of sphingosine-1-phosphate receptor 3 does not affect the skeletal phenotype of mice lacking sphingosine-1-phosphate lyase
    Heckt, Timo
    Brylka, Laura J.
    Neven, Mona
    Amling, Michael
    Schinke, Thorsten
    PLOS ONE, 2019, 14 (07):